CLINICAL SITES

Accelovance owns and operates 7 research-dedicated Clinical Sites located within the United
States. Our sites have been selected to work directly with study Sponsors, both pharmaceutical
and biotech, and have been selected by CROs. In addition, our sites work with Accelovance’s own
CRO team to maximize efficiencies and gain unprecedented control over research programs.
Our site teams receive standardized training that includes a 22-section internally developed study coordinator manual, ICH/GCP, and good documentation practices. Our sites are optimized for
research – they average 3,000 square feet, manage a database that includes over 50,000 active
study volunteers, and have dedicated refrigeration and freezers.